<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Down-regulation of the novel <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> 4 (PDCD4) was demonstrated in several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and regulation by micro-<z:chebi fb="40" ids="33697">RNA</z:chebi> is gaining attention </plain></SENT>
<SENT sid="1" pm="."><plain>However, the clinical significance of the PDCD4 gene in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients still remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>In particular, the significance of PDCD4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in each <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage has not been reported </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we evaluated the prognostic value of PDCD4 expression in each Dukes' stage of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, relationships between the PDCD4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and microRNA-21 (miR-21) were evaluated </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> tissues and <z:mpath ids='MPATH_458'>normal</z:mpath> adjacent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues from 326 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (Dukes' stage A, 44 cases; Dukes' B, 118 cases; Dukes' C, 100 cases; Dukes' D, 64 cases) were examined </plain></SENT>
<SENT sid="6" pm="."><plain>The PDCD4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was investigated by the quantitative real-time RT-PCR method and miR-21 was examined by TaqMan microRNA assays </plain></SENT>
<SENT sid="7" pm="."><plain>The overall survival rates (OS) and disease-free survival rates (DFS) of low PDCD4 patients were significantly worse than those of patients with high expression </plain></SENT>
<SENT sid="8" pm="."><plain>In analysis of each <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage, OS and DFS of patients with low PDCD4 levels were significantly worse than those with high PDCD4 levels in Dukes' stage B and C </plain></SENT>
<SENT sid="9" pm="."><plain>In Dukes' stage D, patients with low PDCD4 expression showed a significant worse OS compared to those of patients with high PDCD4 expression </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, no significant differences were seen between these groups in patients with Dukes' stage A </plain></SENT>
<SENT sid="11" pm="."><plain>PDCD4 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues was an independent prognostic factor in Dukes' stage B, C and D </plain></SENT>
<SENT sid="12" pm="."><plain>Significant inverse correlations were demonstrated between PDCD4 and miR-21 </plain></SENT>
<SENT sid="13" pm="."><plain>The reduced PDCD4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression is associated with poor prognosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with Dukes' stage B, C and D </plain></SENT>
<SENT sid="14" pm="."><plain>Furthermore, PDCD4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were negatively regulated by miR-21in each <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>